Exploring factors related to cervical and endometrial cancer
A Cohort Study of Uterine Malignancies
This study looks at how different factors like lifestyle and health history might be linked to cervical and endometrial cancers in women aged 20-75 who have been diagnosed with these cancers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6200 (estimated) |
| Ages | 20 Years to 75 Years |
| Sex | Female |
| Sponsor | Women's Hospital School Of Medicine Zhejiang University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT05635123 on ClinicalTrials.gov |
What this trial studies
This observational cohort study aims to investigate the relationship between cervical and endometrial cancers and various demographic, lifestyle, and pregnancy-related factors, as well as disease history. It will also analyze biological specimens using omics tests to identify potential diagnostic and prognostic biomarkers. Eligible participants will be women aged 20-75 with a confirmed diagnosis of cervical or endometrial cancer attending health check-ups. The study does not involve any interventions, focusing instead on data collection and analysis.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 20-75 with a first-time pathological diagnosis of cervical or endometrial cancer.
Not a fit: Patients with other types of cancer or those who have undergone hysterectomy or pelvic radiation therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding of factors influencing cervical and endometrial cancer prognosis, potentially guiding better patient management.
How similar studies have performed: While similar studies have explored cancer prognostic factors, this specific approach combining demographic and omics analysis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 20-75 years; * Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time; * Women attending a health check-up; * Obtain informed consent and sign an informed consent form. Exclusion Criteria: * Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment； * Patients with cancer other than cervical cancer or endometrial cancer; * Women who have received hysterectomy or pelvic radiation therapy previously.
Where this trial is running
Hangzhou, Zhejiang
- Women's hospital school of medicine zhejiang university — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: Hui Wang, PhD — Women's Hospital School Of Medicine Zhejiang University
- Study coordinator: Hui Wang, PhD
- Email: wang71hui@zju.deu.cn
- Phone: 0571-89998857
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.